Navigation Links
CytoSorbents Receives Approximately $400,000 in Non-Dilutive Capital from the Sale of Net Operating Loss Carryovers
Date:1/29/2013

span>. The goal of the CytoSorb® cytokine filter is to prevent or treat multiple organ failure, the leading cause of death in the intensive care unit, by reducing the excessive production of cytokines, or "cytokine storm", that could otherwise lead to deadly inflammation, organ injury, and death.  Multiple organ dysfunction syndrome and acute organ failure represents one of the most serious unmet medical needs in modern medicine, claiming millions of lives around the world, at a cost of hundreds of billions of dollars, each year.  By actively addressing one of the most important underlying causes of acute organ failure, CytoSorb® represents a potentially revolutionary advance in the treatment of critical illnesses.

CytoSorbents has received funding from both DARPA and the US Army, and continues to invest significantly in its research and development pipeline.  One of its most advanced products under development is HemoDefend, a blood purification technology platform for the blood transfusion industry intended to reduce transfusion reactions and improve the safety of "old" blood by removing many substances, such as antibodies, free hemoglobin and inflammatory mediators that can cause potentially serious and sometimes fatal transfusion reactions.  CytoSorb® and HemoDefend are just two of a number of different polymers the Company has developed for various medical applications, including improved dialysis, reduction of post-surgical complications in cardiac surgery, treatment of inflammatory and autoimmune disorders, radio-imaging contrast removal in imaging and interventional radiology procedures, and the treatment of rhabdomyolysis, drug overdose, and others. Additional information is available for download on the Company's website: http://www.cytosorbents.com.

Forward-Looking Statements

This press release includes forward-
'/>"/>

SOURCE CytoSorbents Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
2. Leica Biosystems Receives FDA Approval for the Fully Automated Bond Oracle™ HER2 IHC System on the Leica BOND-MAX
3. Nephros Receives 510(k) Clearance for Hemodiafiltration System
4. ProUroCare Medical Receives FDA Clearance for ProUroScan Elasticity Imaging System
5. BONESUPPORT Receives Red Herring 2012 Top 100 Europe Award
6. Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product
7. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
8. Alexza Receives Complete Response Letter for Adasuve™ NDA
9. Ventana Receives FDA Clearance for p53 (DO-7) Image Analysis and Digital Read Applications
10. Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering
11. New Chronic Wound Treatment Device Receives Award from Veterans Healthcare Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... , May 30, 2015  Eisai Inc. announced today the ... that eribulin met the study,s primary endpoint evaluating overall survival ... (ADI), two types of advanced soft tissue sarcoma. These data ... of the American Society of Clinical Oncology (ASCO) in ... conference on Saturday, May 30, and also in an oral ...
(Date:5/30/2015)... May 30, 2015 Caris Life Sciences®, ... promise of precision medicine, today announced the presentation ... utility of Caris Molecular Intelligence®, the company,s panomic ... tumors that share histological features. In separate presentations ... of Clinical Oncology (ASCO) in Chicago, ...
(Date:5/29/2015)... - Alliance Principle Ingredients/Neutrical Solutions Inc., in consultation with ... Health Ginger in Bentonite (NPN 80053535) due to ... The product currently contains levels of lead beyond ... for adult dosing. Ginger in Bentonite ... Alliance Principle Ingredients / Neutrical Solutions Inc. has ...
Breaking Medicine Technology:Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 2Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 3Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 4Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 5Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 6Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 2Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 3Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 4Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 5Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 6
(Date:5/30/2015)... PA (PRWEB) May 30, 2015 You've probably ... cause injury and hearing loss. However, have you found a ... wife from Olathe, Kan., have exactly what you need. , ... removing wax build-up; dirt and dead, dry skin from the ... standard cotton swabs or anything on the market today for ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 Promising clinical ... Oncology (ASCO) Annual Meeting 2015 show activity of the ... one case specifically against brain metastases and in another ... cancer patients. , "I am thrilled to have been ... her early 40s. She didn't have any other great ...
(Date:5/30/2015)... Houston, Texas (PRWEB) May 30, 2015 ... week for 2015’s Aesthetic Meeting, sponsored by the American ... many industry vendors on hand was Zeltiq, the parent ... the aesthetic space, CoolSculpting. With blazing growth, the ... , Zeltiq is currently in the ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 NovaSure® endometrial ... lighten or stop periods, without the side effects ... can reduce or stop menstrual bleeding and works by ... (the part that causes the bleeding), with a quick ... suffer from heavy menstrual bleeding. Many women begin ...
(Date:5/30/2015)... NC (PRWEB) May 30, 2015 The ... that crocidolite asbestos has a high potential to cause ... the full story now on the Surviving Mesothelioma ... Institute of Occupational Medicine in Lodz, Poland found that, ... asbestos workers between 1970 and 2012, all of them ...
Breaking Medicine News(10 mins):Health News:Improved Ear Hygiene Tool Invented by InventHelp Clients (KSC-952) 2Health News:ONT-380 has Stage IV HER2+ Breast Cancer Patient 'Worrying About Normal Stuff Again' 2Health News:ONT-380 has Stage IV HER2+ Breast Cancer Patient 'Worrying About Normal Stuff Again' 3Health News:Dr. Paul Vitenas Meets with Zeltiq President and CEO in Montreal 2Health News:Dr. Paul Vitenas Meets with Zeltiq President and CEO in Montreal 3Health News:Women's Excellence Now Provides NovaSure Treatment 2Health News:New Study Finds Close Link Between Crocidolite Asbestos and Deadly Mesothelioma, According to Surviving Mesothelioma 2
... A unique study conducted by researchers at University of California ... children in the U.S. reveals that it is much higher ... warned about the possibility of back pain as a result ... more than 7000 school-going children present in the emergency room ...
... There is another feather in the coffee cap proposed by ... which says that drinking a cup of coffee with 100 ... procedure for the study involved 15 healthy men aged 26 ... caffeine and then when they consumed a placebo. 100 mg ...
... at preventing amputations and other disease-related complications in diabetics ... State of Tamil Nadu, courtesy a hospital initiative//. ... Initiative in the Community (DAPIC)" programme at Maragal Kandigai ... as a boon. DAPIC seeks to prevent diabetic foot ...
... activity in children's with autism and found that ... The Researchers found //that the autism children's had less ... and imitating others action and expressing facial response. The ... Neuroscience. ,Autism is a developmental disorder that ...
... executed prisoners being sold to foreigners for human transplantation ... Chinese health officials, who have been passive// about the ... widespread prevalence of such an inhuman act. ... from total strangers (were paid for their donation) and ...
... outbreak was detected in Ukraine (Crimea peninsula) and hence domestic ... for the purpose//. Health workers and emergency workers are recruited ... ducks and geese) and destroy them thereby the outbreak can ... bird that was killed. ,Various other ...
Cached Medicine News:Health News:Widespread Commercialisation Of Human Organ Donation In China 2
... The DataMate Laser ... System consists of laser-printable ... closure wristband and laser ... paperwork. The wristbands clear, ...
Use these popular insert style bands to secure a bar code label inside the wristband pocket for maximum convenience and security....
... PDCs computer-generated Thermal Printing Wristbands and ... direct thermal and thermal transfer printers. ... activate a heat-sensitive thermal coating under ... printers use heat to transfer highly ...
... Designed for use in ... Alzheimer units, where you may ... which is easy to apply ... The band's width is increased ...
Medicine Products: